Summit Therapeutics Statistics

Total Valuation

SMMT has a market cap or net worth of $19.96 billion. The enterprise value is $19.67 billion.

Market Cap	19.96B
Enterprise Value	19.67B

Important Dates

The last earnings date was Monday, August 11, 2025, after market close.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

SMMT has 742.85 million shares outstanding. The number of shares has increased by 4.79% in one year.

Current Share Class	742.85M
Shares Outstanding	742.85M
Shares Change (YoY)	+4.79%
Shares Change (QoQ)	+0.61%
Owned by Insiders (%)	80.11%
Owned by Institutions (%)	12.75%
Float	116.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	76.93
P/TBV Ratio	77.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.13, with a Debt / Equity ratio of 0.02.

Current Ratio	5.13
Quick Ratio	4.94
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-308.27

Financial Efficiency

Return on equity (ROE) is -328.30% and return on invested capital (ROIC) is -166.87%.

Return on Equity (ROE)	-328.30%
Return on Assets (ROA)	-142.53%
Return on Invested Capital (ROIC)	-166.87%
Return on Capital Employed (ROCE)	-287.92%
Revenue Per Employee	n/a
Profits Per Employee	-$4.69M
Employee Count	159
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +144.72% in the last 52 weeks. The beta is -1.06, so SMMT's price volatility has been lower than the market average.

Beta (5Y)	-1.06
52-Week Price Change	+144.72%
50-Day Moving Average	24.15
200-Day Moving Average	21.66
Relative Strength Index (RSI)	51.19
Average Volume (20 Days)	2,713,235

Short Selling Information

Short Interest	30.99M
Short Previous Month	28.56M
Short % of Shares Out	26.57%
Short % of Float	n/a
Short Ratio (days to cover)	9.58

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-759.28M
Pretax Income	-161.69M
Net Income	-746.08M
EBITDA	-759.18M
EBIT	-759.28M
Earnings Per Share (EPS)	-$1.01

Full Income Statement

Balance Sheet

The company has $297.87 million in cash and $5.55 million in debt, giving a net cash position of $292.32 million or $0.39 per share.

Cash & Cash Equivalents	297.87M
Total Debt	5.55M
Net Cash	292.32M
Net Cash Per Share	$0.39
Equity (Book Value)	259.44M
Book Value Per Share	0.35
Working Capital	248.92M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$206.88 million and capital expenditures -$494,000, giving a free cash flow of -$207.38 million.

Operating Cash Flow	-206.88M
Capital Expenditures	-494,000
Free Cash Flow	-207.38M
FCF Per Share	-$0.28

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SMMT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.79%
Shareholder Yield	-4.79%
Earnings Yield	-3.74%
FCF Yield	-1.04%

Dividend Details

Analyst Forecast

The average price target for SMMT is $34.67, which is 29.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$34.67
Price Target Difference	29.03%
Analyst Consensus	Strong Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2